Bharat Biotech begins COVAXIN supply to 14 states based on central government's guidance
May 11, 2021, 12:55 IST
Hyderabad, Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.
The states are Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
The Hyderabad-based company said it started the supplies based on the allocations received by the Government of India.
"Requests have been received from other states, & will be processed for distribution based on availability of stocks 24x7," tweeted Bharat Biotech co-founder and Joint Managing Director Suchitra Ella.
The company, however, has not come out with details of the supplies like the number of doses supplied to the states.
Bharat Biotech on April 24 announced pricing for Covaxin. It fixed the price of Covaxin at ₹600 per dose for state governments.
However, it later slashed the price to ₹400. This came after Serum Institute of India (SII) cut the price of Covishield to ₹300 from ₹400 earlier.
The two vaccine makers slashed the prices after the central government reportedly made a request to them amid the row over different pricing for the central and state governments.
For private hospitals, Bharat Biotech fixed the price at ₹1,200 per dose. This is twice the cost fixed for Covishield.
For exports, Bharat Biotech has priced India's first indigenous Covid vaccine at $15-$20 (₹1,125-1,500).
While Bharat Biotech is likely to continue the supplies to the Centre at the same price, SII is seeking to revise this to ₹400.
Both Bharat Biotech and SII have announced that they are reserving 50 per cent of their production capacities for supplies to the central government.
SEE ALSO:
It took one pivot and five years for this EV startup founder to hit the sweet spot for business in India
Clubhouse for Android finally launched as downloads and hype take a plunge
Bandhan Bank falls 4% after reporting an 80% fall in its net profit – positive market trends help it bounce back into the green
Advertisement
The states are Andhra Pradesh, Assam, Chhattisgarh, Delhi, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
The Hyderabad-based company said it started the supplies based on the allocations received by the Government of India.
"Requests have been received from other states, & will be processed for distribution based on availability of stocks 24x7," tweeted Bharat Biotech co-founder and Joint Managing Director Suchitra Ella.
The company, however, has not come out with details of the supplies like the number of doses supplied to the states.
Advertisement
However, it later slashed the price to ₹400. This came after Serum Institute of India (SII) cut the price of Covishield to ₹300 from ₹400 earlier.
The two vaccine makers slashed the prices after the central government reportedly made a request to them amid the row over different pricing for the central and state governments.
For private hospitals, Bharat Biotech fixed the price at ₹1,200 per dose. This is twice the cost fixed for Covishield.
For exports, Bharat Biotech has priced India's first indigenous Covid vaccine at $15-$20 (₹1,125-1,500).
Advertisement
Ever since the launch of Covid vaccination programme in India, Bharat Biotech and SII have been supplying their vaccines to the Centre at ₹150 per dose.While Bharat Biotech is likely to continue the supplies to the Centre at the same price, SII is seeking to revise this to ₹400.
Both Bharat Biotech and SII have announced that they are reserving 50 per cent of their production capacities for supplies to the central government.
SEE ALSO:
It took one pivot and five years for this EV startup founder to hit the sweet spot for business in India
Clubhouse for Android finally launched as downloads and hype take a plunge
Bandhan Bank falls 4% after reporting an 80% fall in its net profit – positive market trends help it bounce back into the green